More than 70,000 women served in Ukraine’s military in 2025, a 20% increase compared with 2022, Ukraine’s Defense Ministry ...
ISLAMABAD: Turkiye has drawn up a plan to establish an assembly facility for its combat drones in Pakistan, with negotiations ...
Interesting Engineering on MSN
Biocomputers: Scientists are turning human brain cells into functional computers
In 2022, the Australian company Cortical Labs made headlines by successfully getting artificial neurons to play the classic ...
Fed Vice Chair Bowman confirms crypto debanking was real. Now banks have permission to serve crypto—but most lack the systems ...
If Europe wants to excel at tech and innovation, it needs to stop throttling the marketplace with regulations and taxes. Nor ...
Legendary inventor Lonnie Johnson, 76, believes his Johnson Thermo-Electrochemical Converter could be his most significant ...
14hon MSN
The Healthcare Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.
Investing in Halozyme Therapeutics is a compelling way to gain exposure to the broader healthcare and biotechnology ...
Elon Musk has lashed out at the European Union, calling for the group to be “abolished” in a string of fiery social media ...
Ultra-processed foods are entrenched in Singaporeans' busy routines and the country's import-reliant food ecosystem. But as ...
To accurately gauge a vaccine’s risks, it is also crucial to compare its side effects with the effects of the illness it ...
Coal is the dirtiest form of fossil fuel, but accounted for 80% of Asean’s power sector emissions in 2023. In 2022, energy ...
Genmab A/S(Nasdaq:GMAB)today announced updated results from two ongoing clinical trials evaluating the efficacy and safety of epcoritamab-bysp, a T-cellengaging antibody administered subcutaneously, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback